Place · Level 3 · Macro
The Dark Matter of Nutrition · why your liver is overbuilt
营养成分表是缺乏症投下的影子 · 酶的手笨是未知分子的指纹 · 次生代谢物是植物的化学武器 · 好处来自轻微的毒 · 提纯加大剂量把 U 型推过峰顶 · 问错的问题与问对的问题
Story path
- 1The label is a shadowThe label is a shadow
- 2Why your liver is overbuiltWhy your liver is overbuilt
- 3Plants didn't make it for youPlants didn't make it for you
- 4A mild poison wakes your defenseA mild poison wakes your defense
- 5Why the pill reversesWhy the pill reverses
- 6What to do with not knowingWhat to do with not knowing
Chapter 1
The label is a shadow
The label is a shadow
Not one of the molecules that make garlic garlic appears on the nutrition label.
The USDA database lists 69 entries for raw garlic. Ascorbic acid (vitamin C) is there; so are amino acids like alanine. What isn't there is allicin — the molecule that makes garlic pungent and antimicrobial. Nor ajoene. Nor p-coumaric acid. Meanwhile researchers recently counted 6,802 small molecules in raw garlic (Menichetti 2024).
Those 69 rows weren't picked at random. To see why the list looks like this, start with a question about the body: what earns a molecule the word essential?
Essential is the gap between two rates
The answer isn't in the food. It's in you, and it's two measurable rates:
how fast you build ithow fast you spend it
Build faster than you spend, and you needn't get it from food. Build slower, and the shortfall has to be eaten. Build at zero while demand isn't zero, and it's essential: cut off the supply and your stores fall at the rate you spend them, and below some line the step that runs on it stops.
What stopping looks like is visible. Without vitamin C you can't build stable collagen, so gums bleed and wounds split open — scurvy. Without thiamine your nerves and heart can't get at the energy in sugar — beriberi. Niacin and vitamin D each collapse in their own way.
So the label is a medical history
Look at the shape of the sieve: to get on the list, a molecule's absence must cause trouble within weeks to months.
That condition selects a very particular class — molecules your body cannot build, without which some step seizes. Twentieth-century nutrition science found them by following the diseases: first the disease, then the molecule.
Which means the sieve necessarily misses an entire class: molecules whose absence causes no trouble in weeks. They have no deficiency disease, so nobody traced a disease back to them, so they aren't on the list.
Not on the list doesn't mean not in the food, and it certainly doesn't mean nothing happens in you. Allicin and ajoene live in that class. Skipping garlic gives you no disease — which is exactly why they're absent from the label, and exactly why they're easy to treat as nonexistent.
The nutrition label is a shadow cast by acute deficiency disease. The analogy stops there: nobody shrank the list on purpose. It was shaped by a question, and the question was what kills people when missing, not what is actually in here.
The USDA database lists 69 entries for raw garlic. Ascorbic acid (vitamin C) is there; so are amino acids like alanine. What isn't there is allicin — the molecule that makes garlic pungent and antimicrobial. Nor ajoene. Nor p-coumaric acid. Meanwhile researchers recently counted 6,802 small molecules in raw garlic (Menichetti 2024).
Those 69 rows weren't picked at random. To see why the list looks like this, start with a question about the body: what earns a molecule the word essential?
Essential is the gap between two rates
The answer isn't in the food. It's in you, and it's two measurable rates:
how fast you build ithow fast you spend it
Build faster than you spend, and you needn't get it from food. Build slower, and the shortfall has to be eaten. Build at zero while demand isn't zero, and it's essential: cut off the supply and your stores fall at the rate you spend them, and below some line the step that runs on it stops.
What stopping looks like is visible. Without vitamin C you can't build stable collagen, so gums bleed and wounds split open — scurvy. Without thiamine your nerves and heart can't get at the energy in sugar — beriberi. Niacin and vitamin D each collapse in their own way.
So the label is a medical history
Look at the shape of the sieve: to get on the list, a molecule's absence must cause trouble within weeks to months.
That condition selects a very particular class — molecules your body cannot build, without which some step seizes. Twentieth-century nutrition science found them by following the diseases: first the disease, then the molecule.
Which means the sieve necessarily misses an entire class: molecules whose absence causes no trouble in weeks. They have no deficiency disease, so nobody traced a disease back to them, so they aren't on the list.
Not on the list doesn't mean not in the food, and it certainly doesn't mean nothing happens in you. Allicin and ajoene live in that class. Skipping garlic gives you no disease — which is exactly why they're absent from the label, and exactly why they're easy to treat as nonexistent.
The nutrition label is a shadow cast by acute deficiency disease. The analogy stops there: nobody shrank the list on purpose. It was shaped by a question, and the question was what kills people when missing, not what is actually in here.
Numbers · how much is tracked
Pull the camera back and the shadow's width is measurable.The USDA's long-tracked core panel is 150 essential micro- and macronutrients, organized mainly around energy metabolism and deficiency: fatty acids, amino acids, sugars, fiber, minerals, vitamins. Since 2003 it has also reported flavonoid content for selected foods, extending the main panel to 188 components (Menichetti 2024).
Set that against the whole of food chemistry:
In 2019 the food compound database FooDB held 26,625 compounds. Those 150 are about 0.5% of it. More than 99% of the biochemicals in food go untracked by any national database — and many of them have documented roles in health and disease (Barabási 2020).By 2024, integrating literature, mass-spectrometry repositories, experiments, composition databases and pathway predictions, that library became 139,443 molecules: 92,612 detected, 46,831 inferred (Menichetti 2024).
But those two numbers can't just be laid side by side — you have to say what each one is first. 26,625 is what FooDB held in 2019. 139,443 is not that same database grown up; it's a separate library the authors assembled (FooDB itself held about 71,000 by 2023). And it matters that 46,831 of them are inferred — computed from pathways and species relatedness, not measured in food.
So using these two to say scientists estimate between twenty thousand and a hundred forty thousand compounds in food is reading two different rulers as one error bar. The honest sentence is just this: the 150-odd we track are a rounding error on every ruler anyone has picked up.
Back to raw garlic: 69 rows against 6,802 molecules — of which 1,984 were actually detected and 4,818 inferred. Count only the detected column and it's still 69 against 1,984. FooDB also records how many bioactivities each molecule has — the alanine on the label has 3, ascorbic acid 105; while the absent allicin has 64, ajoene 46, p-coumaric acid 24 (Menichetti 2024). The missing ones are not nobodies.
A prior offense
This has happened once before. In the 1980s, detractors of the Human Genome Project insisted only the coding regions were worth the cost of decoding — 1.4% of all base pairs — labelling the remaining 98.6% junk DNA. Today it is estimated that 66% of disease-carrying variants sit in exactly those non-coding regions (Barabási 2020).
The analogy stops there — nothing here predicts how many treasures hide among those hundred-odd thousand molecules. It makes one point: a list filtered by a purpose is easily mistaken for the whole. And the purpose that filtered the nutrition label was finding what drops people within weeks.
Chapter 2
Why your liver is overbuilt
Why your liver is overbuilt
You would not build a clumsy enzyme for a molecule you already know.
Start with an enzyme that isn't clumsy, for contrast.
What specificity looks like
Your intestinal wall carries a glucose transporter (SGLT1). It is a severe fusspot: fastest with glucose, a fraction of that with galactose, and it barely moves xylose at all (Wright 2011).
Why can it afford to be so picky? Because it needn't be otherwise. Glucose has exactly one shape, and that shape hasn't changed in hundreds of millions of years. The body knows precisely who it's waiting for, so it built a slot that recognizes that one face. Specificity pays in speed and thrift.
Now look at your liver
Liver cells hold a large family of enzymes, cytochrome P450, whose job is drilling a handle onto foreign molecules: press an oxygen atom on, creating a socket other things can attach to (Guengerich 2008). The most famous member is CYP3A4.
It works the opposite way to that transporter. CYP3A4 is the most promiscuous of the human CYP enzymes: structural work found its active site changes shape around whatever binds, with the pocket volume expanding by more than 80% (Ekroos 2006).
It isn't a lock committed to one set of teeth. It's a hand that reshapes itself to grip things. It grips imprecisely, so it's slow and expensive — but it can grip what it has never met.
Two more properties of this family are just as odd:
Humans carry 57 CYP genes — and the family splits into two populations, which says more than the total does. Only about a dozen handle foreign molecules, clustered in the CYP1, CYP2 and CYP3 families; five of those cover roughly 95% of drug metabolism (Guengerich 2008). The other forty-odd mostly have dedicated endogenous substrates: building steroid hormones and bile acids, making eicosanoids, activating vitamin D (Zanger 2013).And it is exactly the dozen that meet foreign molecules whose substrates overlap and which can be induced — the forty-odd on endogenous duty are specific (Zanger 2013). Inside a single gene family, the body builds specific enzymes for molecules it knows and promiscuous ones for molecules it doesn't. The glucose transporter and the clumsy hand, shrunk to a contrast within one family.They can be induced. When a kind of molecule keeps arriving, the body builds more of the matching enzyme. Capacity can be expanded on demand.
After the handle comes step two: another set of enzymes welds on a big, water-loving, charged tag — glucuronic acid, sulfate, or glutathione (Jancova 2010). Charged things can't slip back through a membrane, so once the kidney filters it, it can never sneak back.
Now set the two side by side
On one side, a glucose transporter, specific to the point of severity. On the other, an enzyme family of dozens of members with overlapping substrates and expandable capacity, far less precise.
Same body. Why two designs?
Because they face different kinds of problem. Glucose's list has one entry and never changes; you can build to order. The list P450 faces is not known to the body in advance, and it differs at every meal.
Against a list whose contents you don't know, specificity is meaningless — you cannot machine a lock for a molecule you haven't met. The only workable design is breadth: build a hand that changes shape, let it grip anything a little and accept that it grips poorly; give it dozens of overlapping colleagues as backup; let it scale on demand.
Which yields the inference this whole story rests on
You would not build something this slow, this expensive, and this imprecise for a known, finite list of molecules. Specificity always pays better. There is only one reason a body accepts the cost of clumsiness: it expects to meet molecules it has never seen, and to meet them often.
The non-specificity of these enzymes is itself the fingerprint of unknown molecules.
And the fingerprint has a provenance. A classic hypothesis for why the P450 superfamily diversified into so many members: a continuing chemical arms race between animals and plants — plants keep producing new defensive molecules, animals keep producing new enzymes to take them apart (Gonzalez & Nebert 1990).
Put differently: your liver was shaped into its present form by somebody else's chemical weapons.
The next scene goes to see who made those weapons, and why. For the full picture of the liver's two steps, see the hepatic island.
Start with an enzyme that isn't clumsy, for contrast.
What specificity looks like
Your intestinal wall carries a glucose transporter (SGLT1). It is a severe fusspot: fastest with glucose, a fraction of that with galactose, and it barely moves xylose at all (Wright 2011).
Why can it afford to be so picky? Because it needn't be otherwise. Glucose has exactly one shape, and that shape hasn't changed in hundreds of millions of years. The body knows precisely who it's waiting for, so it built a slot that recognizes that one face. Specificity pays in speed and thrift.
Now look at your liver
Liver cells hold a large family of enzymes, cytochrome P450, whose job is drilling a handle onto foreign molecules: press an oxygen atom on, creating a socket other things can attach to (Guengerich 2008). The most famous member is CYP3A4.
It works the opposite way to that transporter. CYP3A4 is the most promiscuous of the human CYP enzymes: structural work found its active site changes shape around whatever binds, with the pocket volume expanding by more than 80% (Ekroos 2006).
It isn't a lock committed to one set of teeth. It's a hand that reshapes itself to grip things. It grips imprecisely, so it's slow and expensive — but it can grip what it has never met.
Two more properties of this family are just as odd:
Humans carry 57 CYP genes — and the family splits into two populations, which says more than the total does. Only about a dozen handle foreign molecules, clustered in the CYP1, CYP2 and CYP3 families; five of those cover roughly 95% of drug metabolism (Guengerich 2008). The other forty-odd mostly have dedicated endogenous substrates: building steroid hormones and bile acids, making eicosanoids, activating vitamin D (Zanger 2013).And it is exactly the dozen that meet foreign molecules whose substrates overlap and which can be induced — the forty-odd on endogenous duty are specific (Zanger 2013). Inside a single gene family, the body builds specific enzymes for molecules it knows and promiscuous ones for molecules it doesn't. The glucose transporter and the clumsy hand, shrunk to a contrast within one family.They can be induced. When a kind of molecule keeps arriving, the body builds more of the matching enzyme. Capacity can be expanded on demand.
After the handle comes step two: another set of enzymes welds on a big, water-loving, charged tag — glucuronic acid, sulfate, or glutathione (Jancova 2010). Charged things can't slip back through a membrane, so once the kidney filters it, it can never sneak back.
Now set the two side by side
On one side, a glucose transporter, specific to the point of severity. On the other, an enzyme family of dozens of members with overlapping substrates and expandable capacity, far less precise.
Same body. Why two designs?
Because they face different kinds of problem. Glucose's list has one entry and never changes; you can build to order. The list P450 faces is not known to the body in advance, and it differs at every meal.
Against a list whose contents you don't know, specificity is meaningless — you cannot machine a lock for a molecule you haven't met. The only workable design is breadth: build a hand that changes shape, let it grip anything a little and accept that it grips poorly; give it dozens of overlapping colleagues as backup; let it scale on demand.
Which yields the inference this whole story rests on
You would not build something this slow, this expensive, and this imprecise for a known, finite list of molecules. Specificity always pays better. There is only one reason a body accepts the cost of clumsiness: it expects to meet molecules it has never seen, and to meet them often.
The non-specificity of these enzymes is itself the fingerprint of unknown molecules.
And the fingerprint has a provenance. A classic hypothesis for why the P450 superfamily diversified into so many members: a continuing chemical arms race between animals and plants — plants keep producing new defensive molecules, animals keep producing new enzymes to take them apart (Gonzalez & Nebert 1990).
Put differently: your liver was shaped into its present form by somebody else's chemical weapons.
The next scene goes to see who made those weapons, and why. For the full picture of the liver's two steps, see the hepatic island.
gonzalez-nebert-1990-p450-warfarezanger-schwab-2013-cyp-drug-metabolism
Chapter 3
Plants didn't make it for you
Plants didn't make it for you
When a plant built those molecules, it wasn't thinking about you. It was thinking about killing the insect chewing on it.
Detonate on bite
Cut a head of garlic, chew a mouthful of broccoli, and the smell that hits your nose has only just appeared. It isn't there in the intact plant cell.
The brassica design is explicit: a molecule called a glucosinolate and an enzyme called myrosinase sit packed in separate compartments of the cell, each quiet. Break the cell wall, the two mix, the enzyme cleaves the glucosinolate, and isothiocyanates are produced — that pungency is them (Fahey 2001).
It's a chemical landmine wired to detonate on bite: no energy spent while idle, triggered only at the moment of chewing, and going off inside the mouth doing the chewing.
These molecules do no work for the plant
Collectively they're called secondary metabolites. Secondary means they take no part in the plant's own growth and energy production — that's primary metabolism. Secondary metabolites are for dealing with the outside.
Of the several thousand garlic molecules counted in the previous scene, the researchers' own words: many are secondary metabolites acting as the plant's chemical defense against stressors such as predators and extreme weather conditions (Menichetti 2024).
Defense against whom? Insects, fungi, bacteria, the sun. Not you.
The pungency in your mouth is a stray round
To state it plainly: you and the caterpillar on the broccoli are biochemical relatives. A molecule that can jam its enzymes can often reach yours too — you're simply far bigger, so the same mouthful lands a far smaller dose on you.
So when you eat plants, you're eating a poison prepared for someone else. An accident, not a design.
This scene welds the first two together
Return to scene two's question: why did your liver build an entire infrastructure for molecules it has never met?
Here's the answer. Your ancestors ate other species' chemical weapons every day, for hundreds of millions of years. The weapons kept updating, because the plants were evolving too. So the disassembly tools couldn't be bespoke; they had to be general, expandable, and broad to the point of clumsiness. The arms-race hypothesis from the previous scene (Gonzalez & Nebert 1990) is about exactly these two things driving each other.
It also sets up the next scene
If these molecules' day job is to mildly interfere with your biochemistry, then their benefit to you is unlikely to be doing your work for you. Far more likely: they poke you gently, and your response to being poked is where the benefit comes from.
That idea has a name — xenohormesis: many dietary phytochemicals are toxins the plant uses against insects and stress, but on our side, at the low doses humans actually eat, they activate adaptive cellular stress responses and thereby confer stress resistance and other benefits (Surh 2011).
The next scene takes that sentence apart, down to which atom of which molecule the poke lands on.
Detonate on bite
Cut a head of garlic, chew a mouthful of broccoli, and the smell that hits your nose has only just appeared. It isn't there in the intact plant cell.
The brassica design is explicit: a molecule called a glucosinolate and an enzyme called myrosinase sit packed in separate compartments of the cell, each quiet. Break the cell wall, the two mix, the enzyme cleaves the glucosinolate, and isothiocyanates are produced — that pungency is them (Fahey 2001).
It's a chemical landmine wired to detonate on bite: no energy spent while idle, triggered only at the moment of chewing, and going off inside the mouth doing the chewing.
These molecules do no work for the plant
Collectively they're called secondary metabolites. Secondary means they take no part in the plant's own growth and energy production — that's primary metabolism. Secondary metabolites are for dealing with the outside.
Of the several thousand garlic molecules counted in the previous scene, the researchers' own words: many are secondary metabolites acting as the plant's chemical defense against stressors such as predators and extreme weather conditions (Menichetti 2024).
Defense against whom? Insects, fungi, bacteria, the sun. Not you.
The pungency in your mouth is a stray round
To state it plainly: you and the caterpillar on the broccoli are biochemical relatives. A molecule that can jam its enzymes can often reach yours too — you're simply far bigger, so the same mouthful lands a far smaller dose on you.
So when you eat plants, you're eating a poison prepared for someone else. An accident, not a design.
This scene welds the first two together
Return to scene two's question: why did your liver build an entire infrastructure for molecules it has never met?
Here's the answer. Your ancestors ate other species' chemical weapons every day, for hundreds of millions of years. The weapons kept updating, because the plants were evolving too. So the disassembly tools couldn't be bespoke; they had to be general, expandable, and broad to the point of clumsiness. The arms-race hypothesis from the previous scene (Gonzalez & Nebert 1990) is about exactly these two things driving each other.
It also sets up the next scene
If these molecules' day job is to mildly interfere with your biochemistry, then their benefit to you is unlikely to be doing your work for you. Far more likely: they poke you gently, and your response to being poked is where the benefit comes from.
That idea has a name — xenohormesis: many dietary phytochemicals are toxins the plant uses against insects and stress, but on our side, at the low doses humans actually eat, they activate adaptive cellular stress responses and thereby confer stress resistance and other benefits (Surh 2011).
The next scene takes that sentence apart, down to which atom of which molecule the poke lands on.
gonzalez-nebert-1990-p450-warfare
Chapter 4
A mild poison wakes your defense
A mild poison wakes your defense
Broccoli is good for you not because it cleared away free radicals on your behalf. It's because it mildly poisoned you, forcing you to turn your own defenses up.
This scene takes that sentence apart down to the atoms.
Step one · a carbon short of electrons
You chew broccoli, myrosinase cleaves a glucosinolate into sulforaphane, and the landmine from the last scene has just gone off (Fahey 2001).
Sulforaphane carries an isothiocyanate group, written —N=C=S. The carbon in the middle has electrons pulled away by the nitrogen and sulfur flanking it, leaving it electron-poor — chemically, electrophilic. An electrophilic carbon has a fixed temperament: it hunts for electron-rich things to crash into, then sticks covalently, unbreakably.
The most electron-rich and most easily struck thing in a cell is the sulfur on the amino acid cysteine.
Step two · what it hits is a sensor
Cells hold a protein called KEAP1, carrying a row of cysteines. Its everyday job is concrete: it is a bridge.
One end of the bridge is the Cul3 ubiquitin ligase; the other is a transcription factor called Nrf2. KEAP1 keeps handing Nrf2 to the ligase, and the ligase tags Nrf2 for destruction. So Nrf2 is dismantled as fast as it's built, its concentration stays low, and the genes it governs stay low too (Hu 2011).
Note that this is the resting state. Your cells build Nrf2 every moment and destroy it every moment. That isn't waste — it's a loaded spring, held down by a hand.
The electrophilic carbon of sulforaphane crashes into exactly that hand. It sticks covalently onto KEAP1's cysteines; number 151 (Cys151) is among the most readily modified of them, and modifying it is required for sulforaphane's activity (Hu 2011).
Step three · the hand lets go
The bridge breaks, Nrf2 stops being tagged, so it accumulates, enters the nucleus, pairs with a small Maf protein, binds a switch sequence in the genes called the ARE, and starts transcribing cytoprotective enzymes (Hu 2011).
And who gets transcribed? Here's the elegant loop:
Glutathione S-transferase — recognize it? That's the weld-a-water-balloon-onto-the-handle step from scene two. What this plant toxin does is turn up the very production line that clears it.NAD(P)H quinone oxidoreductase 1 and heme oxygenase-1, two more cytoprotective tools (Hu 2011).And one that matters more: through the ARE, Nrf2 governs the rate-limiting enzyme of glutathione synthesis, glutamate cysteine ligase (GCL, built from the GCLC and GCLM subunits) (Lu 2013).
That last one is this scene's landing point. Glutathione is your cells' principal reducing agent — and one of the water balloons welded on in scene two. Sulforaphane cleared no free radical for you. It isn't even a scavenger. What it did was widen the rate-limiting valve on the machine that builds scavengers.
So the benefit runs the other way
Not: you swallow a scavenger and it cleans for you.
But: you swallow a mild poison; your cell notices something is covalently attacking its cysteines, releases the hand that was holding the spring down, and raises its own defensive capacity.
The benefit is built by you. The plant only pressed a button.
The button's existence makes the point too: your cells carry a sensor dedicated to noticing that an electrophile has arrived, and that sensor is wired to the master switch for defensive genes. Bodies don't install sensors for events that never happen — the same argument as scene two. The Keap1-Nrf2 pathway is regarded as the most important one underlying the health benefits of dietary phytochemicals (Surh 2011).
The analogy stops here
If a metaphor is wanted: this is more like a fire drill than a delivery of fire extinguishers. The drill is a nuisance, but afterwards your capacity to put out fires is genuinely higher.
The analogy stops there — in the real event there is no fire and no alarm bell. There is an electron-poor carbon hitting a sulfur atom, and a bridge coming apart.
This scene takes that sentence apart down to the atoms.
Step one · a carbon short of electrons
You chew broccoli, myrosinase cleaves a glucosinolate into sulforaphane, and the landmine from the last scene has just gone off (Fahey 2001).
Sulforaphane carries an isothiocyanate group, written —N=C=S. The carbon in the middle has electrons pulled away by the nitrogen and sulfur flanking it, leaving it electron-poor — chemically, electrophilic. An electrophilic carbon has a fixed temperament: it hunts for electron-rich things to crash into, then sticks covalently, unbreakably.
The most electron-rich and most easily struck thing in a cell is the sulfur on the amino acid cysteine.
Step two · what it hits is a sensor
Cells hold a protein called KEAP1, carrying a row of cysteines. Its everyday job is concrete: it is a bridge.
One end of the bridge is the Cul3 ubiquitin ligase; the other is a transcription factor called Nrf2. KEAP1 keeps handing Nrf2 to the ligase, and the ligase tags Nrf2 for destruction. So Nrf2 is dismantled as fast as it's built, its concentration stays low, and the genes it governs stay low too (Hu 2011).
Note that this is the resting state. Your cells build Nrf2 every moment and destroy it every moment. That isn't waste — it's a loaded spring, held down by a hand.
The electrophilic carbon of sulforaphane crashes into exactly that hand. It sticks covalently onto KEAP1's cysteines; number 151 (Cys151) is among the most readily modified of them, and modifying it is required for sulforaphane's activity (Hu 2011).
Step three · the hand lets go
The bridge breaks, Nrf2 stops being tagged, so it accumulates, enters the nucleus, pairs with a small Maf protein, binds a switch sequence in the genes called the ARE, and starts transcribing cytoprotective enzymes (Hu 2011).
And who gets transcribed? Here's the elegant loop:
Glutathione S-transferase — recognize it? That's the weld-a-water-balloon-onto-the-handle step from scene two. What this plant toxin does is turn up the very production line that clears it.NAD(P)H quinone oxidoreductase 1 and heme oxygenase-1, two more cytoprotective tools (Hu 2011).And one that matters more: through the ARE, Nrf2 governs the rate-limiting enzyme of glutathione synthesis, glutamate cysteine ligase (GCL, built from the GCLC and GCLM subunits) (Lu 2013).
That last one is this scene's landing point. Glutathione is your cells' principal reducing agent — and one of the water balloons welded on in scene two. Sulforaphane cleared no free radical for you. It isn't even a scavenger. What it did was widen the rate-limiting valve on the machine that builds scavengers.
So the benefit runs the other way
Not: you swallow a scavenger and it cleans for you.
But: you swallow a mild poison; your cell notices something is covalently attacking its cysteines, releases the hand that was holding the spring down, and raises its own defensive capacity.
The benefit is built by you. The plant only pressed a button.
The button's existence makes the point too: your cells carry a sensor dedicated to noticing that an electrophile has arrived, and that sensor is wired to the master switch for defensive genes. Bodies don't install sensors for events that never happen — the same argument as scene two. The Keap1-Nrf2 pathway is regarded as the most important one underlying the health benefits of dietary phytochemicals (Surh 2011).
The analogy stops here
If a metaphor is wanted: this is more like a fire drill than a delivery of fire extinguishers. The drill is a nuisance, but afterwards your capacity to put out fires is genuinely higher.
The analogy stops there — in the real event there is no fire and no alarm bell. There is an electron-poor carbon hitting a sulfur atom, and a bridge coming apart.
Chapter 5
Why the pill reverses
Why the pill reverses
The same molecule is good for you from a vegetable, and can harm you once purified, dosed up, and packed into a capsule.
The previous scene's mechanism carries this consequence built in.
The shape is a U
If the benefit comes from a mild poisoning, then dose and effect cannot be a straight rising line.
Too low: the sensor is never touched and nothing happens.About right: the sensor gets touched, defense is turned up, net result good.Too high: the electrophile is no longer touching only KEAP1's cysteines. Cysteines are everywhere in a cell, and so is everything else it can stick to covalently. At that point it is simply what it always was — a poison.
So there's a peak in the middle. Purifying and dosing up pushes you off the rising limb and straight over that peak. Food struggles to do this, because you'd have to eat a mountain of broccoli to reach the amount in one capsule.
And a second route, more insidious
High-dose antioxidants do something else: they erase the signal itself.
The Ristow 2009 trial is explicit. People exercised; half also took vitamin C 1000 mg/day plus vitamin E 400 IU/day, half took none.
The result: the improvement in insulin sensitivity appeared only in the group not taking antioxidants.
Worse is what follows. Exercise normally induces the body's own reactive-oxygen defenses (superoxide dismutases 1 and 2, glutathione peroxidase) to be built in greater quantity; with antioxidant supplementation, that induction was blocked too (Ristow 2009).
Look carefully at what happened. The reactive oxygen produced in exercising muscle isn't only damage — it's a signal. The body reads it and learns to raise its defenses and metabolic capacity. Swallow high-dose antioxidants, neutralize the signal before it lands, and the body never gets the memo, so it never adjusts.
You removed the alarm. The room is cleaner, at the price that the fire brigade never comes again.
This is the mirror image of scene four: there, a little stress turns defense up; here, a big dose flattens the stress, so defense never turns up at all.
The beta-carotene affair, stated precisely
The most famous reversal usually gets waved through in a sentence: antioxidants turned out to cause cancer. That sentence is lazy. The real mechanism needs three conditions at once.
Start with the chemistry. Burton and Ingold found in 1984 that beta-carotene is an antioxidant that watches the oxygen pressure: only at partial pressures of oxygen significantly below 150 torr — the pressure in normal air — is it a good radical-trapping antioxidant. Raise the oxygen pressure and it not only loses antioxidant activity but shows an autocatalytic pro-oxidant effect, especially at relatively high concentrations (Burton 1984).
Most tissues in the body sit at the low end of that range, which is why it behaves itself under ordinary conditions.
But a smoker's lung isn't at the low end. It's among the highest-oxygen places in the body, and it's flooded with oxidants from smoke.
So the three conditions line up:
Purified — stripped of the hundreds of molecules that arrive with it inside a carrot.High dose — far beyond what anyone eats from vegetables.A specific environment — that lung, with high oxygen pressure plus smoke oxidants.
Hence the two trials stopped early. In ATBC (1994, male smokers, 20 mg/day beta-carotene) lung cancers rose about 18% (ATBC 1994). In CARET (Omenn 1996, beta-carotene plus retinol, smokers and asbestos-exposed workers) lung cancers rose about 28% (Omenn 1996).
Here is the part that must be exact: one word, hormesis, does not explain this. Slapping a U-curve on it and calling it finished uses a handsome word to cover three specific conditions. What is actually operating is the combination of those three — remove any one and the conclusion might change.
Don't fuse three trials into one
While we're here, separate the standard confusion:
ATBC (1994) — vitamin E and beta-carotene, male smokers, lung cancer up about 18%.CARET (Omenn 1996) — beta-carotene plus retinol, smokers and asbestos-exposed, lung cancer up about 28%.SELECT (Klein 2011) — selenium and vitamin E, healthy men, prostate cancer up about 17%. Not beta-carotene, not smokers, not lungs.
The three point at one lesson: purified high-dose antioxidants aren't free. But their mechanisms can't be borrowed across. The vitamin E in SELECT doesn't travel beta-carotene's oxygen-pressure road.
And one number, retired
That antioxidant capacity score once printed on packaging (ORAC) had its entire database withdrawn by the USDA in 2012. The stated reason is direct: in-vitro antioxidant capacity does not predict in-vivo health effects (USDA 2012).
Why it can't predict, scene four already answered. What matters was never how many radicals the molecule traps in a test tube. It's whether it can reach KEAP1's row of cysteines inside your cells. Those are entirely different things, and a molecule can excel at the first while being incapable of the second.
The previous scene's mechanism carries this consequence built in.
The shape is a U
If the benefit comes from a mild poisoning, then dose and effect cannot be a straight rising line.
Too low: the sensor is never touched and nothing happens.About right: the sensor gets touched, defense is turned up, net result good.Too high: the electrophile is no longer touching only KEAP1's cysteines. Cysteines are everywhere in a cell, and so is everything else it can stick to covalently. At that point it is simply what it always was — a poison.
So there's a peak in the middle. Purifying and dosing up pushes you off the rising limb and straight over that peak. Food struggles to do this, because you'd have to eat a mountain of broccoli to reach the amount in one capsule.
And a second route, more insidious
High-dose antioxidants do something else: they erase the signal itself.
The Ristow 2009 trial is explicit. People exercised; half also took vitamin C 1000 mg/day plus vitamin E 400 IU/day, half took none.
The result: the improvement in insulin sensitivity appeared only in the group not taking antioxidants.
Worse is what follows. Exercise normally induces the body's own reactive-oxygen defenses (superoxide dismutases 1 and 2, glutathione peroxidase) to be built in greater quantity; with antioxidant supplementation, that induction was blocked too (Ristow 2009).
Look carefully at what happened. The reactive oxygen produced in exercising muscle isn't only damage — it's a signal. The body reads it and learns to raise its defenses and metabolic capacity. Swallow high-dose antioxidants, neutralize the signal before it lands, and the body never gets the memo, so it never adjusts.
You removed the alarm. The room is cleaner, at the price that the fire brigade never comes again.
This is the mirror image of scene four: there, a little stress turns defense up; here, a big dose flattens the stress, so defense never turns up at all.
The beta-carotene affair, stated precisely
The most famous reversal usually gets waved through in a sentence: antioxidants turned out to cause cancer. That sentence is lazy. The real mechanism needs three conditions at once.
Start with the chemistry. Burton and Ingold found in 1984 that beta-carotene is an antioxidant that watches the oxygen pressure: only at partial pressures of oxygen significantly below 150 torr — the pressure in normal air — is it a good radical-trapping antioxidant. Raise the oxygen pressure and it not only loses antioxidant activity but shows an autocatalytic pro-oxidant effect, especially at relatively high concentrations (Burton 1984).
Most tissues in the body sit at the low end of that range, which is why it behaves itself under ordinary conditions.
But a smoker's lung isn't at the low end. It's among the highest-oxygen places in the body, and it's flooded with oxidants from smoke.
So the three conditions line up:
Purified — stripped of the hundreds of molecules that arrive with it inside a carrot.High dose — far beyond what anyone eats from vegetables.A specific environment — that lung, with high oxygen pressure plus smoke oxidants.
Hence the two trials stopped early. In ATBC (1994, male smokers, 20 mg/day beta-carotene) lung cancers rose about 18% (ATBC 1994). In CARET (Omenn 1996, beta-carotene plus retinol, smokers and asbestos-exposed workers) lung cancers rose about 28% (Omenn 1996).
Here is the part that must be exact: one word, hormesis, does not explain this. Slapping a U-curve on it and calling it finished uses a handsome word to cover three specific conditions. What is actually operating is the combination of those three — remove any one and the conclusion might change.
Don't fuse three trials into one
While we're here, separate the standard confusion:
ATBC (1994) — vitamin E and beta-carotene, male smokers, lung cancer up about 18%.CARET (Omenn 1996) — beta-carotene plus retinol, smokers and asbestos-exposed, lung cancer up about 28%.SELECT (Klein 2011) — selenium and vitamin E, healthy men, prostate cancer up about 17%. Not beta-carotene, not smokers, not lungs.
The three point at one lesson: purified high-dose antioxidants aren't free. But their mechanisms can't be borrowed across. The vitamin E in SELECT doesn't travel beta-carotene's oxygen-pressure road.
And one number, retired
That antioxidant capacity score once printed on packaging (ORAC) had its entire database withdrawn by the USDA in 2012. The stated reason is direct: in-vitro antioxidant capacity does not predict in-vivo health effects (USDA 2012).
Why it can't predict, scene four already answered. What matters was never how many radicals the molecule traps in a test tube. It's whether it can reach KEAP1's row of cysteines inside your cells. Those are entirely different things, and a molecule can excel at the first while being incapable of the second.
burton-1984-beta-carotene-oxygen
Chapter 6
What to do with not knowing
What to do with not knowing
What nutrients does this food have is the wrong question.
Where it goes wrong, the first five scenes have answered: the question assumes the answer lives on a label, and that label was sieved by whether absence causes trouble within weeks. Most of what you want to know isn't on this side of the sieve.
So what should you ask? Two things:
Does this mouthful bring a wide enough variety of unfamiliar molecules?Is any one of them outrunning the speed at which I clear it?
Both land on something concrete in the body. The first lands on KEAP1's row of cysteines: somebody has to touch it. The second lands on the capacity of the P450-plus-phase-two line: don't touch too hard.
The division of labor with the additives story
The zero-added story says: the body reads only three things — which molecule, how much, and what it arrived with; and once the clearance line saturates, dose versus harm turns from a slope into a hinge.
This story adds a premise to those three: the list of which molecule is far longer than you thought, and you don't hold the full copy.
Together the conclusion changes shape. Since you know neither the complete list nor how to compute each dose, the strategy cannot be to evaluate them one by one. Only two remain:
Keep that infrastructure built for unknown molecules busy, and busy with variety.Don't let any single molecule sit at the capacity ceiling for long.
Now dismantle two opposite errors
Not knowing gets used in two opposite directions. Neither holds.
First: unknown equals dangerous.
The instinct is natural — most of these molecules were never studied, so avoid them, pick the shortest ingredient list.
But it defeats itself. Among those hundred-odd thousand untracked molecules, the most vicious are precisely the natural ones: tetrodotoxin, aflatoxin — made by living things to kill other living things. Meanwhile you successfully process a pile of unstudied plant molecules every single day, using exactly the machinery of scene two. Your liver was built for this, and it wins every day.
So fearing the unknown means fearing something you succeed at daily. If you must rank by danger, be wary of mold and natural toxins, not the long chemical names of legal additives — that ranking is exactly inverted.
Second: unknown equals magical.
This one costs more. The whole superfood pitch is built on it: since science tracks only a fraction, my as-yet-undiscovered miracle active compound cannot be falsified.
Scene four supplies the test: for a molecule to act on you, it has to actually touch something in your body — hit a cysteine, wedge into a pocket, plug a gate. No contact, no event.
And the argument treats all plants equally. Tens of thousands of unknown molecules is not one berry's selling point. It is every plant's default configuration, including the cheapest cabbage at the market. Anyone selling it as exclusive is charging you for a universal fact.
So what can you take away
Not a list of what to eat. The entire content of this story is that nobody has that list.
Three judgments:
Variety beats betting. You don't know the list, so you can't pick the winner. Rotating is admitting you don't know — the only honest response.Whole food beats the purified capsule. The reason is scene five: purified plus high dose is the fastest way over the peak of the U.When you see the word unknown, ask whether it's being used to frighten you or to sell to you. Both exploit the same fact, and that fact only says your body was ready for it long ago.
Know that it is so, and know why it is so. This story's why is unusual: the infrastructure you carry for the unknown, by simply existing, is telling you that food is far more than what's on the label. You don't need to know those molecules. You only need to know your body has been handling them for you all along.
Where it goes wrong, the first five scenes have answered: the question assumes the answer lives on a label, and that label was sieved by whether absence causes trouble within weeks. Most of what you want to know isn't on this side of the sieve.
So what should you ask? Two things:
Does this mouthful bring a wide enough variety of unfamiliar molecules?Is any one of them outrunning the speed at which I clear it?
Both land on something concrete in the body. The first lands on KEAP1's row of cysteines: somebody has to touch it. The second lands on the capacity of the P450-plus-phase-two line: don't touch too hard.
The division of labor with the additives story
The zero-added story says: the body reads only three things — which molecule, how much, and what it arrived with; and once the clearance line saturates, dose versus harm turns from a slope into a hinge.
This story adds a premise to those three: the list of which molecule is far longer than you thought, and you don't hold the full copy.
Together the conclusion changes shape. Since you know neither the complete list nor how to compute each dose, the strategy cannot be to evaluate them one by one. Only two remain:
Keep that infrastructure built for unknown molecules busy, and busy with variety.Don't let any single molecule sit at the capacity ceiling for long.
Now dismantle two opposite errors
Not knowing gets used in two opposite directions. Neither holds.
First: unknown equals dangerous.
The instinct is natural — most of these molecules were never studied, so avoid them, pick the shortest ingredient list.
But it defeats itself. Among those hundred-odd thousand untracked molecules, the most vicious are precisely the natural ones: tetrodotoxin, aflatoxin — made by living things to kill other living things. Meanwhile you successfully process a pile of unstudied plant molecules every single day, using exactly the machinery of scene two. Your liver was built for this, and it wins every day.
So fearing the unknown means fearing something you succeed at daily. If you must rank by danger, be wary of mold and natural toxins, not the long chemical names of legal additives — that ranking is exactly inverted.
Second: unknown equals magical.
This one costs more. The whole superfood pitch is built on it: since science tracks only a fraction, my as-yet-undiscovered miracle active compound cannot be falsified.
Scene four supplies the test: for a molecule to act on you, it has to actually touch something in your body — hit a cysteine, wedge into a pocket, plug a gate. No contact, no event.
And the argument treats all plants equally. Tens of thousands of unknown molecules is not one berry's selling point. It is every plant's default configuration, including the cheapest cabbage at the market. Anyone selling it as exclusive is charging you for a universal fact.
So what can you take away
Not a list of what to eat. The entire content of this story is that nobody has that list.
Three judgments:
Variety beats betting. You don't know the list, so you can't pick the winner. Rotating is admitting you don't know — the only honest response.Whole food beats the purified capsule. The reason is scene five: purified plus high dose is the fastest way over the peak of the U.When you see the word unknown, ask whether it's being used to frighten you or to sell to you. Both exploit the same fact, and that fact only says your body was ready for it long ago.
Know that it is so, and know why it is so. This story's why is unusual: the infrastructure you carry for the unknown, by simply existing, is telling you that food is far more than what's on the label. You don't need to know those molecules. You only need to know your body has been handling them for you all along.
Red flags · and one thing for people on medication
This story is about mechanism. It is not medical advice and does not replace a doctor's judgment.One thing if you take medication
Scene two noted that P450 enzymes can be induced — use them more and the body builds more. They can also be suppressed.
And what suppresses them is often a plant. Grapefruit is the famous case: a class of molecules it carries inactivates CYP3A4 in the intestinal wall, so the fraction of a drug that should have been dismantled before reaching the blood isn't, and the same tablet can deliver considerably more drug into circulation (Bailey 2013). Dozens of medications are affected, from lipid-lowering drugs to certain blood-pressure drugs and immunosuppressants.
Two lessons run in opposite directions:
It confirms this whole story: your drug and the plant's secondary metabolites are competing for the same production line. The body can't tell which is medicine and which is fruit. It only reads molecules.It also warns that eating more plants isn't a zero-cost move for someone on medication. If you want to change things, ask a doctor or pharmacist rather than experimenting.
Don't handle these yourself — see a doctor
Unexplained weight lossPersistent fatigue with pallorBlack or bloody stools, or food sticking when you swallowRecurrent fever or night sweats
One more deserves its own line: a rash, swelling of the lips or tongue, or difficulty breathing after eating something. That is what an acute allergic reaction looks like, and it needs immediate care rather than watchful waiting.
bailey-2013-grapefruit-drug